Total Funding
56
52
Total FundingPost-IPO Equity raised
Growth Score
-4 pts
Heat Score
-2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
147909
CohBar is a clinical-stage biotechnology company that focuses on the research and development of mitochondria based therapeutics.
John Amatruda: Founder- Nir Barzilai: Founder
About the Company
CohBar is a clinical-stage biotechnology company that focuses on the research and development of mitochondria based therapeutics. It has developed proprietary mitochondria based therapeutic (MBT) platform technology, using cell-based assays and animal models of disease, to rapidly identify naturally occurring MDPs with promising biological
activity.
The company was founded in 2007 and is headquartered in Menlo Park, California.
Women Founded
